Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
F.J. Ampudia-Blasco, J. Rosenstock.
Estrategias de insulinización en la diabetes mellitus tipo 2.
Av Diabetol, 24 (2008), pp. 7-20
[2.]
I.B. Hirsch.
Insulin analogues.
N Engl J Med, 352 (2005), pp. 174-183
[3.]
T. Danne, J. Aman, E. Schober, et al.
A comparison of postprandial and preprandial administration of insulin aspart in children and adolescents with type 1 diabetes.
Diabetes Care, 26 (2003), pp. 2359-2364
[4.]
S.A. Weinzimer, C. Ternand, C. Howard, et al.
A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes.
Diabetes Care, 31 (2008), pp. 210-215
[5.]
E. Mathiesen, B. Kinsley, S.A. Amiel, et al.
Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women.
Diabetes Care, 30 (2007), pp. 771-776
[6.]
S. Heller, P. Damm, H. Mersebach, et al.
Hypoglycemia in type 1 diabetic pregnancy: role of preconception insulin aspart treatment in a randomized study.
Diabetes Care, 33 (2010), pp. 473-477
[7.]
D.J. Pettitt, P. Ospina, C. Howard, H. Zisser, L. Jovanovic.
Efficacy, safety and lack of immunogenicity of insulin aspart compared with regular human insulin for women with gestational diabetes mellitus.
Diabet Med, 24 (2007), pp. 1129-1135
[8.]
S.R. Heller, S. Colagiuri, S. Vaaler, et al.
Hypoglycaemia with insulin aspart: a double-blind, randomised, crossover trial in subjects with type 1 diabetes.
Diabet Med, 21 (2004), pp. 769-775
[9.]
R.R. Holman, A.J. Farmer, M.J. Davies, et al.
Three-year efficacy of complex insulin regimens in type 2 diabetes.
N Engl J Med, 361 (2009), pp. 1736-1747
[10.]
L. Meneghini, H. Mersebach, A. Kumar, A.L. Svendsen, K. Hermansen.
Comparison of 2 intensification regimens with rapid-acting insulin aspart in type 2 diabetes mellitus inadequately controlled by once-daily insulin detemir and oral antidiabetes drugs: the step-wise randomized study.
Endocr Pract, 17 (2011), pp. 727-736
[11.]
C. Muñoz, G. Villanueva, L. Fogg, et al.
Impact of a subcutaneous insulin protocol in the emergency department: Rush Emergency Department Hyperglycemia Intervention (REDHI).
J Emerg Med, (2011), pp. 493-498
[12.]
R. Krones, C. Schütte, T. Heise.
The rapid-acting properties of insulin aspart are preserved in elderly people with type 2 diabetes.
Diabetes Obes Metab, 11 (2009), pp. 41-44
[13.]
G. Holmes, L. Galitz, P. Hu, W. Lyness.
Pharmacokinetics of insulin aspart in obesity, renal impairment, or hepatic impairment.
Br J Clin Pharmacol, 60 (2005), pp. 469-476
Copyright © 2012. Sociedad Española de Diabetes